Alembic Pharmaceuticals Limited — Others, 07-05-2025: Copy of Newspaper Publication

Alembic Pharmaceuticals has announced the transfer of equity shares to the Investor Education and Protection Fund (IEPF) for shareholders with unclaimed dividends for seven years or more. The company has informed affected shareholders individually and published details online for verification. If no response is received by the deadline, shares will be moved to the IEPF Demat Account and physical certificates cancelled. Shareholders can still reclaim their shares and dividends from the IEPF Authority through the prescribed process. This ensures better compliance and protects shareholder interests.